We've found
3,204
archived clinical trials in
Healthy Studies
We've found
3,204
archived clinical trials in
Healthy Studies
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
Updated: 10/5/2015
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
Status: Enrolling
Updated: 10/5/2015
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
Updated: 10/5/2015
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.
Updated: 10/6/2015
A Phase 1 Randomized, Open-Label, 2-Sequence, 2-Period Crossover Study Of The Effect Of Multiple Doses Of PD-0332991 On Midazolam Pharmacokinetics In Healthy Women of Non-Childbearing Potential
Status: Enrolling
Updated: 10/6/2015
A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.
Updated: 10/6/2015
A Phase 1 Randomized, Open-Label, 2-Sequence, 2-Period Crossover Study Of The Effect Of Multiple Doses Of PD-0332991 On Midazolam Pharmacokinetics In Healthy Women of Non-Childbearing Potential
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers
Updated: 10/6/2015
A Phase 1 Open-Label Fixed-Sequence Two-Period Crossover Study Of The Effect Of Multiple Doses Of Tamoxifen On PD-0332991 Pharmacokinetics In Healthy Male Volunteers
Status: Enrolling
Updated: 10/6/2015
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers
Updated: 10/6/2015
A Phase 1 Open-Label Fixed-Sequence Two-Period Crossover Study Of The Effect Of Multiple Doses Of Tamoxifen On PD-0332991 Pharmacokinetics In Healthy Male Volunteers
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials
Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)
Updated: 10/6/2015
A Phase 1, Open-Label Fixed-Sequence 2-Period Crossover Study Of Palbociclib In Healthy Subjects To Investigate The Potential Effect Of Antacid Treatment On The Pharmacokinetics Of A Single Oral Dose Administered Under Fasted Conditions
Status: Enrolling
Updated: 10/6/2015
Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)
Updated: 10/6/2015
A Phase 1, Open-Label Fixed-Sequence 2-Period Crossover Study Of Palbociclib In Healthy Subjects To Investigate The Potential Effect Of Antacid Treatment On The Pharmacokinetics Of A Single Oral Dose Administered Under Fasted Conditions
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials
Effect of Pharmacist Initiated Recommendations On Prescribing For Participants In the Senior MEDS Personalized Medication Review
Updated: 10/6/2015
Participant Characteristics, Medication Utilization, and the Effects of Pharmacist Initiated Recommendations On the Prescribing For Participants In the Senior MEDS Personalized Medication Review for Adults Age 55 and Older
Status: Enrolling
Updated: 10/6/2015
Effect of Pharmacist Initiated Recommendations On Prescribing For Participants In the Senior MEDS Personalized Medication Review
Updated: 10/6/2015
Participant Characteristics, Medication Utilization, and the Effects of Pharmacist Initiated Recommendations On the Prescribing For Participants In the Senior MEDS Personalized Medication Review for Adults Age 55 and Older
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials
Myogenic and Osteogenic Responses to eXercise and Ibuprofen
Updated: 10/7/2015
COX Inhibition & Musculoskeletal Responses to Exercise
Status: Enrolling
Updated: 10/7/2015
Myogenic and Osteogenic Responses to eXercise and Ibuprofen
Updated: 10/7/2015
COX Inhibition & Musculoskeletal Responses to Exercise
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
Updated: 10/7/2015
A Single Center, Open-label, Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin in Healthy Subjects
Status: Enrolling
Updated: 10/7/2015
Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
Updated: 10/7/2015
A Single Center, Open-label, Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin in Healthy Subjects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Radiolabeled Study of AG-221 in Healthy Male Subjects.
Updated: 10/9/2015
A Phase 1, Open-Label, Two-Part Study to Evaluate the Metabolism, Excretion, and Absolute Bioavailability of AG-221 in Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/9/2015
Radiolabeled Study of AG-221 in Healthy Male Subjects.
Updated: 10/9/2015
A Phase 1, Open-Label, Two-Part Study to Evaluate the Metabolism, Excretion, and Absolute Bioavailability of AG-221 in Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials
Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men
Status: Enrolling
Updated: 10/12/2015
Updated: 10/12/2015
Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men
Status: Enrolling
Updated: 10/12/2015
Updated: 10/12/2015
Click here to add this to my saved trials
Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology
Updated: 10/13/2015
Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology
Status: Enrolling
Updated: 10/13/2015
Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology
Updated: 10/13/2015
Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Circulatory Levels of Irisin in Response to Chronic Resistance Training
Updated: 10/19/2015
Circulatory Levels of Irisin in Response to Chronic Resistance Training
Status: Enrolling
Updated: 10/19/2015
Circulatory Levels of Irisin in Response to Chronic Resistance Training
Updated: 10/19/2015
Circulatory Levels of Irisin in Response to Chronic Resistance Training
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Circulatory Levels of Irisin in Response to Acute Resistance Training
Updated: 10/19/2015
Circulatory Levels of Irisin in Response to Acute Resistance Training
Status: Enrolling
Updated: 10/19/2015
Circulatory Levels of Irisin in Response to Acute Resistance Training
Updated: 10/19/2015
Circulatory Levels of Irisin in Response to Acute Resistance Training
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
To Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities
Updated: 10/19/2015
A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study in Healthy Subjects to Determine the Fasting Bioequivalence of Oxycodone Tamper Resistant (OTR) 80-mg Tablets Manufactured at the Totowa, NJ Facility to Oxycodone Tamper Resistant (OTR) 80-mg Tablets Manufactured at the Wilson, NC Facility
Status: Enrolling
Updated: 10/19/2015
To Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities
Updated: 10/19/2015
A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study in Healthy Subjects to Determine the Fasting Bioequivalence of Oxycodone Tamper Resistant (OTR) 80-mg Tablets Manufactured at the Totowa, NJ Facility to Oxycodone Tamper Resistant (OTR) 80-mg Tablets Manufactured at the Wilson, NC Facility
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment
Updated: 10/20/2015
A Phase I, Open-Label, Parallel-Group, Multiple-Dose Study to Determine the Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment and in Healthy Control Volunteers
Status: Enrolling
Updated: 10/20/2015
Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment
Updated: 10/20/2015
A Phase I, Open-Label, Parallel-Group, Multiple-Dose Study to Determine the Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment and in Healthy Control Volunteers
Status: Enrolling
Updated: 10/20/2015
Click here to add this to my saved trials
Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment
Updated: 10/20/2015
A Phase I, Open-Label, Parallel-Group, Multiple-Dose Study to Determine the Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment and in Healthy Control Volunteers
Status: Enrolling
Updated: 10/20/2015
Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment
Updated: 10/20/2015
A Phase I, Open-Label, Parallel-Group, Multiple-Dose Study to Determine the Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment and in Healthy Control Volunteers
Status: Enrolling
Updated: 10/20/2015
Click here to add this to my saved trials
The Effect of Rifapentine on Raltegravir
Updated: 10/21/2015
The Effect of Rifapentine on Plasma Concentrations of Raltegravir
Status: Enrolling
Updated: 10/21/2015
The Effect of Rifapentine on Raltegravir
Updated: 10/21/2015
The Effect of Rifapentine on Plasma Concentrations of Raltegravir
Status: Enrolling
Updated: 10/21/2015
Click here to add this to my saved trials
The Effect of Rifapentine on Raltegravir
Updated: 10/21/2015
The Effect of Rifapentine on Plasma Concentrations of Raltegravir
Status: Enrolling
Updated: 10/21/2015
The Effect of Rifapentine on Raltegravir
Updated: 10/21/2015
The Effect of Rifapentine on Plasma Concentrations of Raltegravir
Status: Enrolling
Updated: 10/21/2015
Click here to add this to my saved trials
Frequency of Aerobic/Resistance Training in Older Women
Updated: 10/26/2015
Frequency of Aerobic/Resistance Training in Older Women
Status: Enrolling
Updated: 10/26/2015
Frequency of Aerobic/Resistance Training in Older Women
Updated: 10/26/2015
Frequency of Aerobic/Resistance Training in Older Women
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants
Updated: 10/26/2015
A Phase 1, Open-Label, Randomized, Three-Way Crossover Study Evaluating the Relative Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Subjects
Status: Enrolling
Updated: 10/26/2015
Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants
Updated: 10/26/2015
A Phase 1, Open-Label, Randomized, Three-Way Crossover Study Evaluating the Relative Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Subjects
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning
Updated: 10/27/2015
A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/27/2015
A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning
Updated: 10/27/2015
A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/27/2015
Click here to add this to my saved trials
A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning
Updated: 10/27/2015
A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/27/2015
A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning
Updated: 10/27/2015
A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/27/2015
Click here to add this to my saved trials
A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning
Updated: 10/27/2015
A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/27/2015
A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning
Updated: 10/27/2015
A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/27/2015
Click here to add this to my saved trials
Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
Updated: 10/27/2015
Scan Re-Scan Pancreatic Beta Cell Imaging Using PET Imaging and 18F-FP-DTBZ
Status: Enrolling
Updated: 10/27/2015
Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
Updated: 10/27/2015
Scan Re-Scan Pancreatic Beta Cell Imaging Using PET Imaging and 18F-FP-DTBZ
Status: Enrolling
Updated: 10/27/2015
Click here to add this to my saved trials
Safety & Health Improvement: Enhancing Law Enforcement Departments
Updated: 10/28/2015
Safety & Health Improvement: Enhancing Law Enforcement Departments
Status: Enrolling
Updated: 10/28/2015
Safety & Health Improvement: Enhancing Law Enforcement Departments
Updated: 10/28/2015
Safety & Health Improvement: Enhancing Law Enforcement Departments
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Health Protection & Promotion for Oregon Correctional Officers
Updated: 10/28/2015
Health Protection & Promotion for Oregon Correctional Officers
Status: Enrolling
Updated: 10/28/2015
Health Protection & Promotion for Oregon Correctional Officers
Updated: 10/28/2015
Health Protection & Promotion for Oregon Correctional Officers
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
Updated: 10/29/2015
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
Status: Enrolling
Updated: 10/29/2015
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
Updated: 10/29/2015
Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Computer-Based Training for Cognitive Enhancement: Classroom Study
Updated: 10/29/2015
Computer-Based Training for Cognitive Enhancement: Classroom Study
Status: Enrolling
Updated: 10/29/2015
Computer-Based Training for Cognitive Enhancement: Classroom Study
Updated: 10/29/2015
Computer-Based Training for Cognitive Enhancement: Classroom Study
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Computer-Based Training for Cognitive Enhancement: In Home Study
Updated: 10/29/2015
Computer-Based Training for Cognitive Enhancement: In Home Study
Status: Enrolling
Updated: 10/29/2015
Computer-Based Training for Cognitive Enhancement: In Home Study
Updated: 10/29/2015
Computer-Based Training for Cognitive Enhancement: In Home Study
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
Updated: 10/29/2015
An Observational Study Evaluating Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
Status: Enrolling
Updated: 10/29/2015
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
Updated: 10/29/2015
An Observational Study Evaluating Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Evaluation of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of E2609 in Healthy Subjects
Updated: 11/2/2015
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E2609 in Healthy Subjects
Status: Enrolling
Updated: 11/2/2015
Evaluation of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of E2609 in Healthy Subjects
Updated: 11/2/2015
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E2609 in Healthy Subjects
Status: Enrolling
Updated: 11/2/2015
Click here to add this to my saved trials
A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects
Updated: 11/2/2015
A Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects
Status: Enrolling
Updated: 11/2/2015
A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects
Updated: 11/2/2015
A Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects
Status: Enrolling
Updated: 11/2/2015
Click here to add this to my saved trials
A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil
Status: Enrolling
Updated: 11/2/2015
Updated: 11/2/2015
A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil
Status: Enrolling
Updated: 11/2/2015
Updated: 11/2/2015
Click here to add this to my saved trials
An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects
Status: Enrolling
Updated: 11/2/2015
Updated: 11/2/2015
An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects
Status: Enrolling
Updated: 11/2/2015
Updated: 11/2/2015
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects
Updated: 11/2/2015
A Randomized, Double-Blind, Placebo-Controlled, Single Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects
Status: Enrolling
Updated: 11/2/2015
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects
Updated: 11/2/2015
A Randomized, Double-Blind, Placebo-Controlled, Single Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects
Status: Enrolling
Updated: 11/2/2015
Click here to add this to my saved trials
A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects
Updated: 11/2/2015
A Randomized, Double-Blind, Placebo and Active-Controlled, Single-Dose, 4-Treatment Crossover Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects
Status: Enrolling
Updated: 11/2/2015
A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects
Updated: 11/2/2015
A Randomized, Double-Blind, Placebo and Active-Controlled, Single-Dose, 4-Treatment Crossover Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects
Status: Enrolling
Updated: 11/2/2015
Click here to add this to my saved trials
Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects
Updated: 11/2/2015
An Open-Label Study to Assess the Drug-Drug Interaction Potential of a Single 1200 mg IV Dose of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects.
Status: Enrolling
Updated: 11/2/2015
Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects
Updated: 11/2/2015
An Open-Label Study to Assess the Drug-Drug Interaction Potential of a Single 1200 mg IV Dose of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects.
Status: Enrolling
Updated: 11/2/2015
Click here to add this to my saved trials
A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion
Status: Enrolling
Updated: 11/2/2015
Updated: 11/2/2015
A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion
Status: Enrolling
Updated: 11/2/2015
Updated: 11/2/2015
Click here to add this to my saved trials
A Study to Determine the Effect of a High-Fat Meal on the Rate and Extent of E2006 Absorption in Healthy Subjects
Status: Enrolling
Updated: 11/2/2015
Updated: 11/2/2015
A Study to Determine the Effect of a High-Fat Meal on the Rate and Extent of E2006 Absorption in Healthy Subjects
Status: Enrolling
Updated: 11/2/2015
Updated: 11/2/2015
Click here to add this to my saved trials
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Status: Enrolling
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Status: Enrolling
Updated: 11/4/2015
Click here to add this to my saved trials
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Status: Enrolling
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Status: Enrolling
Updated: 11/4/2015
Click here to add this to my saved trials
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Status: Enrolling
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Updated: 11/4/2015
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
Status: Enrolling
Updated: 11/4/2015
Click here to add this to my saved trials
LMA Cuff Pressure and LMA-induced Complications
Updated: 11/5/2015
Using the Natural Recoil of the Inflating Syringe as a Safety Valve to Limit LMA Cuff Pressure and Decrease LMA-Induced Complications
Status: Enrolling
Updated: 11/5/2015
LMA Cuff Pressure and LMA-induced Complications
Updated: 11/5/2015
Using the Natural Recoil of the Inflating Syringe as a Safety Valve to Limit LMA Cuff Pressure and Decrease LMA-Induced Complications
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
LMA Cuff Pressure and LMA-induced Complications
Updated: 11/5/2015
Using the Natural Recoil of the Inflating Syringe as a Safety Valve to Limit LMA Cuff Pressure and Decrease LMA-Induced Complications
Status: Enrolling
Updated: 11/5/2015
LMA Cuff Pressure and LMA-induced Complications
Updated: 11/5/2015
Using the Natural Recoil of the Inflating Syringe as a Safety Valve to Limit LMA Cuff Pressure and Decrease LMA-Induced Complications
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users
Updated: 11/9/2015
A Phase 1, Single-Dose, Double-Blind, Placebo-and Active-Controlled, Randomized, 6-way Crossover Human Abuse Liability Evaluation of ALKS 5461
Status: Enrolling
Updated: 11/9/2015
A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users
Updated: 11/9/2015
A Phase 1, Single-Dose, Double-Blind, Placebo-and Active-Controlled, Randomized, 6-way Crossover Human Abuse Liability Evaluation of ALKS 5461
Status: Enrolling
Updated: 11/9/2015
Click here to add this to my saved trials
A Water Consumption Study of ALKS 5461 in Healthy Volunteers
Updated: 11/9/2015
A Phase 1 Study to Evaluate the Impact of Water Consumption on the Pharmacokinetics of Sublingually Administered ALKS 5461
Status: Enrolling
Updated: 11/9/2015
A Water Consumption Study of ALKS 5461 in Healthy Volunteers
Updated: 11/9/2015
A Phase 1 Study to Evaluate the Impact of Water Consumption on the Pharmacokinetics of Sublingually Administered ALKS 5461
Status: Enrolling
Updated: 11/9/2015
Click here to add this to my saved trials
A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers
Updated: 11/9/2015
A Phase 1 Study to Evaluate the Impact of CYP3A4 Induction on the Single Dose Pharmacokinetics of ALKS 5461
Status: Enrolling
Updated: 11/9/2015
A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers
Updated: 11/9/2015
A Phase 1 Study to Evaluate the Impact of CYP3A4 Induction on the Single Dose Pharmacokinetics of ALKS 5461
Status: Enrolling
Updated: 11/9/2015
Click here to add this to my saved trials
Intralumenal Effects on Cholesterol Absorption/Synthesis
Updated: 11/10/2015
Intralumenal Effects on Cholesterol Absorption/Synthesis
Status: Enrolling
Updated: 11/10/2015
Intralumenal Effects on Cholesterol Absorption/Synthesis
Updated: 11/10/2015
Intralumenal Effects on Cholesterol Absorption/Synthesis
Status: Enrolling
Updated: 11/10/2015
Click here to add this to my saved trials
Effect of Teduglutide on Gastric Emptying in Healthy Subjects
Updated: 11/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dosing, Parallel Group Study to Assess the Effects of Teduglutide (ALX-0600) on Gastric Emptying in Healthy Subjects
Status: Enrolling
Updated: 11/10/2015
Effect of Teduglutide on Gastric Emptying in Healthy Subjects
Updated: 11/10/2015
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dosing, Parallel Group Study to Assess the Effects of Teduglutide (ALX-0600) on Gastric Emptying in Healthy Subjects
Status: Enrolling
Updated: 11/10/2015
Click here to add this to my saved trials
Reliability and Validity of Online Cognitive Assessments
Updated: 11/11/2015
Reliability and Validity of Online Cognitive Assessments
Status: Enrolling
Updated: 11/11/2015
Reliability and Validity of Online Cognitive Assessments
Updated: 11/11/2015
Reliability and Validity of Online Cognitive Assessments
Status: Enrolling
Updated: 11/11/2015
Click here to add this to my saved trials
Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation
Updated: 11/11/2015
Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation
Status: Enrolling
Updated: 11/11/2015
Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation
Updated: 11/11/2015
Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation
Status: Enrolling
Updated: 11/11/2015
Click here to add this to my saved trials